Healthcare & Pharmaceuticals

From patient care to innovation, we're supporting the future of healthcare.

Overview

About 10% of Australia's GDP is spent on health. What are we getting for that? We get more than just a trip to the doctor, that's for sure. Modern healthcare encompasses extraordinary technical advances, commercialisation, patents, trade marks and other IP, and a highly regulated pharmaceutical sector.

There's innovation too in the way health services are developed and delivered, from research and health precincts through to healthcare infrastructure such as hospitals or aged care homes which integrate the latest technology with old-fashioned care and compassion. For those running a healthcare facility, there are also medical negligence and disciplinary proceedings. Underlying it all is the need to protect, manage and utilise vast amounts of sensitive data within strict privacy laws. And then there are the business issues: corporate governance, real estate acquisition, planning approvals, investments, and exit strategies.

We might not be able to solve physical headaches as easily as you can, but we know how to deal with the legal headaches – and even stop them from happening.

Our team to support you

Toolkits

Insights
Australian Budget 2026-27: sweeping tax changes to bring foreseeable (and unintended) consequences for investors
14 May 2026 | Article
Read Insights
Australia patents update: Full Court reinstates problematic best method requirement for divisional patents
30 Apr 2026 | Article
Read Insights
The Middle East conflict: what Australian corporates should do now, and into the future
29 Apr 2026 | Article
Read Insights
Emergency FWC review of fuel costs road transport order – key dates
29 Apr 2026 | Article
Read Insights
Fuel cost recovery mechanisms in road transport contractual chains: what you need to know
20 Apr 2026 | Article
Read Insights
Broad spectrum protection: TGA releases consultation paper on the future of sunscreen regulation
10 Apr 2026 | Article
Read Insights
The role of AI in corporate governance: Lessons from ASIC v Bekier
10 Apr 2026 | Article
Read Insights
ASX-plained: Simplification of the ASX Corporate Governance Principles now underway
2 Apr 2026 | Article
Read Insights
New mandatory medical device reporting: key implications for facilities and sponsors
2 Apr 2026 | Article
Read Insights
The one that got away: High Court rules against Katy Perry in trade mark battle
2 Apr 2026 | Article
Read Insights
Getting ready for Victoria's plans to enshrine WFH rights for all workers
27 Mar 2026 | Article
Read Insights
Workplace surveillance: A thing of the past? Not so fast
24 Mar 2026 | Article
Read Insights